Looking for funding? Subscribe to news
close icon
Shape

Intrapharm

Specialist pharmaceutical company

Company bio

BGF invested in Intrapharm in August 2014 and supported the company's acquisition of three specialist pharma companies: Peckforton Pharmaceuticals, Alvedon, Aquamax. Following a period of sustained growth, with revenues increasing from £4m p.a. at the point of BGF’s investment to £12m in November 2015, the business was acquired by German pharmaceutical company RIEMSER Pharma GmbH. BGF exited its minority equity stake in the business, with all shareholders realising a strong return.

Company
information

Head office

Maidenhead

 

CEO

Kevin James

 

COO

Shafiq Choudhary

 

Website

intrapharmlabs.com

BGF office

Reading

 

BGF team

James Austin

Greg Norman

 

Investment between

Aug 2014 – Nov 2015

 

Total BGF investment

£2m

Sign-up to BGF investment alerts